Vous êtes ici : Home   >   Research Groups   >   [CBAT] Chimie Biologique et Applications Thérapeutiques

[CBAT] Chimie Biologique et Applications Thérapeutiques

Head of the research group

Directeur de Recherche au CNRS

Year of creation of the group - 2014


Le Bel Institute, 4th floor North

Secretarial and accounting services provided by

Geneviève STOLL
email : genstoll@unistra.fr
Phone : +33 (0)3 68 85 13 64logo

Permanent members

  • SEEMANN Myriam
    Directeur de recherche CNRS
    email : mseemann@unistra.fr
    Phone : +33 (0)3 68 85 16 92

Non-permanent members

PhD students

  • Barbara LABORIE
  • Mickaël MAUGER

Description of the research group

The research activities of the CBAT team are focused on the study of proteins with therapeutic potential, particularly in the field of antibacterials. Most of our projects aim at fighting bacteria for which current treatments are scares or ineffective. Antibiotic resistance is, in fact, a very serious health threat as some infections are already impossible to threat with the existing therapeutic repertoire.

The CBAT team offers the possibility of doing internships (Bachelor, Master, engineering schools students …) and to prepare a PhD thesis at the University of Strasbourg. The team provides a training through research at the interface of chemistry and biology giving the opportunity to gain a multidisciplinary mindset and skill set. Postdoctorates, doctorates, trainees may visit the laboratories of our collaborators notably within the framework of crystallography experiments at the European Synchrotron Radiation Facility (ERSF, Grenoble).

Research topics

The research performed in the CBAT team requires a multidisciplinary approach combining bioorganic and bioinorganic chemistry, enzymology, microbiology, molecular biology, crystallography and spectroscopies. The team has all the expertise to produce and characterize oxygen-sensitive metalloenzymes.

  • Investigation of the catalytic mechanism of enzymes and metalloenzymes (synthesis of molecular tools, SAR studies, site-directed mutagenesis…)
  • Enzyme and metalloenzyme inhibition (synthesis of inhibitors, determination of inhibition constants and inhibition mode, structure determination of enzyme-inhibitor complex…)
  • Characterization of Fe/S enzymes (EPR and Mössbauer spectroscopies…)
  • Identification of biological partners involved in the reduction of metalloenzymes
  • Characterization of protein assembly involved in electron transfer
  • Identification of new targets for the development of novel antibacterial agents
  • Drug discovery: Mechanistic-based, structure-based, fragment-based drug design, virtual screening, HTS…)
  • Inhibition tests on enzymes and bacteria


thèmes de recherche

PhD postion offer

Dans le cadre d'une action Marie Sklodowska Curie (ITN) financée par la commission européenne, nous disposons d'une offre de thèse en chimie médicinale (ESR 7) portant sur l'inhibition des enzymes IspG/GcpE et IspH/LytB dans le but de développer de nouveaux antibiotiques.

Les candidats éligibles ne devront pas avoir résidé ou travaillé en France pendant plus de 12 mois au cours des 3 dernières années.

Les informations pour postuler se trouvent sur le site suivant: http://mepanti.hips-wordpress.helmholtz-hzi.de/

Date limite de reception des candidatures: 03/07/2020

- - - - - -

In the frame of a Marie Sklodowska Curie Training Network (ITN) funded by the Europeen commission, we are offering a PhD position in Medicinal Chemistry (ESR 7) to focus on the inhibition of IspG/GcpE and IspH/LytB enzymes in the search of new antibiotics.

To be eligible as an early stage researcher (ESR), the candidate should not have lived or worked more than 12 months in the last 3 years in the country he/she applies .

Application details can be found at: http://mepanti.hips-wordpress.helmholtz-hzi.de/

Deadline to apply: 03/07/2020

List of equipment and instruments

  • Glove-box under anaerobic conditions dedicated to the purification of oxygen sensitive enzymes
  • Protein purification systems
  • Equipment for organic chemistry

Selection of key publications

P. Chaignon, B. E. Petit, B. Vincent, L. Allouche, M. Seemann
Methylerythritol Phosphate Pathway: Enzymatic Evidence for a Rotation in the LytB/IspH-Catalyzed Reaction.
Chem. Eur. J., 2020, 26, 1032-1036. DOI: https://doi.org/10.1002/chem.201904676

Zoljargal Baatarkhuu, Philippe Chaignon, Franck Borel, Jean-Luc Ferrer, Alain Wagner, Myriam Seemann
Synthesis and Kinetic evaluation of an azido analogue of methylerythritol phosphate: a Novel Inhibitor of E. coliYgbP/IspD
Scientific REPORTS | (2018) 8:17892 | DOI:10.1038/s41598-018-35586-y

F. Borel, E. Barbier, S. Krasutsky, K. Janthawornpong, P. Chaignon, C. Dale Poulter, J.-L. Ferrer, M. Seemann
Further insight into crystal structures of E. coli IspH/LytB in complex with two potent inhibitors of the MEP pathway: a starting point for rational design of new antimicrobials.
ChemBioChem 2017, 18, 2137-2144

Faus, A. Reinhard, S. Rackwitz, J. A. Wolny, K. Schlage, H.-C. Wille, A. Chumakov, S. Krasutsky, P. Chaignon, C. D. Poulter, M. Seemann, V. Schünemann
Isoprenoid biosynthesis in pathogenic bacteria: Nuclear Resonance Vibrational Spectroscopy provides insight into the unusual [4Fe-4S] cluster of the E. coli LytB/IspH protein.
Angew. Chem. Int. Ed.
2015, 54, 12584-12587

L. Y. So, W.-Y.Chen, D. C. Lacap-Bugler, M. Seemann, R. M. Watt
pZMO7-Derived shuttle vectors for heterologous protein expression and proteomic applications in the ethanol-producing bacterium Zymomonas mobilis.
BMC Microbiology
2014, 14, 68-84

K. Janthawornpong, S. Krasutsky, P. Chaignon, M. Rohmer, C.D. Poulter, M. Seemann 
Inhibition of IspH, a [4Fe-4S]2+ enzyme involved in the biosynthesis of isoprenoids via the MEP pathway.
J. Am. Chem. Soc.
2013, 135, 1816-1822

A. Ahrens-Botzong, K. Janthawornpong, J. A. Wolny, E. Ngouamegne Tambou, M. Rohmer, S. Krasutsky, C.D. Poulter, V. Schünemann, M. Seemann
Biosynthesis of isoprene units: Mössbauer spectroscopy of substrate and inhibitor binding to the [4Fe-4S] cluster of the LytB/IspH enzyme.
Angew. Chem. Int. Ed.
2011, 50, 11976-11979

Photo gallery

A small overview of our research group